The medications used to treat T2DM used to be called ‘oral hypoglycaemic medicines’; however, most of the incretin agonists require subcutaneous injection, and only sulfonylureas and meglitinides cause hypoglycaemia. Here, GCG is linked to type 2 diabetes mellitus.